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Purpose
Cancer is one of the most major health issues worldwide.
An increasing number of cancer patients received surgery,
chemotherapy and radiotherapy. However, there usually
exists some side-effects. Traditional Chinese Medicine
(TCM) is one of the most common complementary thera-
pies used in Taiwan. We designed a randomized, double-
blind and placebo-controlled clinical trial to evaluate the
role of TCM on patients with cancer.
Methods
Inclusion criteria were being diagnosed as cancer patients
within 3 years and received chemotherapy (CT) or radio-
therapy (RT), age above 18 years old. Exclusion criteria
were pregnancy, brain metastasis, or receiving drugs for
other clinical trials. These patients were separated to an
intervention group (Sheng-Mai-san) and a placebo group
for 4 weeks using a randomized, double-blind principle.
EORTC QOL-C30 was used to evaluate quality of life.
General data, CBC, GOT, GPT, BUN, creatinine, and
CEA were also recorded. These data were collected at
baseline and one month after using drugs. Enrolled
patients were prescribed sealed granules, which contain
therapeutic drugs or placebo. We used paired-t tests for
statistical analysis.
Results
Forty patients were recruited in this study. Twenty-nine
completed the EORTC QOL C30 questionnaire and
laboratory data. There were fourteen patients in the
intervention group including twelve females and two
males. Fifteen patients were in the placebo group,
including nine females and six males. Patient character-
istics of the two groups were similar. We compared the
total scales of EORTC-C30 pretreatment and post treat-
ment and there were significant differences in insomnia,
constipation and financial difficulties in intervention
group (p<0.05). Besides, we also noted significant
decreases in WBC in the placebo group (p=0.01). But
neutrophils increased significantly (p<0.05 ) and average
WBC increased (still within normal limits) in the inter-
vention group.
Conclusion
TCM (Sheng-Mai-san) improved several symptoms in
cancer patients undergoing CR or RT and prevented
decreases of WBC. TCM may be a complementary therapy
for cancer patients undergoing CT/RT.
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